Drug Regulatory Authority of Pakistan (DRAP)

The Drug Regulatory Authority of Pakistan is the central authority responsible for regulating the manufacturing, import, export, distribution, and registration of pharmaceutical products, medical devices, and health-related items in Pakistan. For businesses operating in the healthcare, pharmaceutical, and medical sectors, dealing with DRAP is mandatory to ensure that products meet safety, quality, and efficacy standards. However, the regulatory framework is highly technical, documentation-intensive, and strictly monitored, making professional handling essential for smooth approvals and compliance.

One of the most critical aspects of DRAP is product registration, which is required before any pharmaceutical or medical product can be legally marketed or distributed. This process involves detailed documentation, including formulation data, clinical information, and compliance with regulatory standards. Even minor errors or incomplete submissions can lead to delays or rejection. Through One Window Legal, we ensure that all documentation is accurately prepared and submitted, significantly improving the chances of successful registration.

Another key area involves licensing for manufacturers, importers, and distributors. Businesses must obtain the appropriate licenses to operate within the pharmaceutical and healthcare sector. These licenses require strict adherence to regulatory guidelines, inspections, and approvals. Many companies face challenges in understanding these requirements or preparing the necessary documentation. Our team provides complete assistance in securing licenses, ensuring full compliance with DRAP regulations.

Compliance and regulatory updates are also crucial in this sector, as DRAP frequently revises policies related to drug safety, pricing, and quality control. Staying updated and compliant is essential to avoid penalties, product recalls, or business disruptions. One Window Legal offers ongoing advisory services, helping clients remain aligned with current regulations and maintain smooth operations.

For businesses dealing with imports and exports of pharmaceutical products, DRAP approvals are required along with coordination with other regulatory bodies. This process involves detailed documentation and strict scrutiny. We assist clients in managing these approvals efficiently, ensuring that products meet all regulatory standards and are cleared without unnecessary delays.

In addition, handling objections, inspections, and regulatory notices from DRAP requires professional expertise and strategic response. Our team provides representation and guidance in such cases, ensuring that all issues are addressed effectively while protecting the client’s business interests.

Choosing One Window Legal for DRAP-related services means partnering with experts who understand the complexities of the pharmaceutical regulatory environment. We simplify procedures, ensure accurate compliance, and provide end-to-end support, allowing businesses to focus on growth while we manage the regulatory challenges with precision and reliability.